Use of magnetic resonance imaging (MRI) biomarkers may identify patients who are at high risk for conversion from clinically isolated syndrome (CIS) to clinically definite multiple sclerosis (CDMS).
Recent study results show no benefit from percutaneous transluminal venous angioplasty in improving symptoms of patients with multiple sclerosis.
News and updates about the 2013 Annual Meeting of the Consortium of Multiple Sclerosis Centers.
Approved by the FDA in September 2012, Genzyme’s Aubagio (teriflunomide tablets) is a once-daily oral treatment shown to reduce relapses, slow physical disability progression and reduce the number of brain lesions detected by magnetic resonance imaging (MRI) in patients with relapsing forms of multiple sclerosis (MS).
Following the presentation of a new research initiative designed to map the human brain, set out in the State of the Union address, the Obama administration has unveiled the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, according to a White House press release issued April 2.
